Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Franklin Wireless Fkwl Stock Defensive In Downturns Price At 3.79 Up 2.43 20260328 Nmi Stock Analysis Nuveen Municipal Income Fund Inc. 1.91 Fall To 10.25 Key Insights 20260401 Is Edesa Edsa Stock Consolidating Price At 6.14 Up 10.63 20260402 Is Nu Nu Stock Safe To Buy Now Price At 14.91 Up 0.27 20260410 Hrtx Stock Analysis Heron Therapeutics Inc. Biotech Stock At 0.8 After Minor Daily Dip 20260403 What Is The Bull Case For Fuelcell Energy Fcel Stock Price At 6.60 Up 2.17 20260402 Is Stride Lrn Stock Moving Sideways Price At 89.17 Down 1.33 20260410 AEON AEON Bio posts far wider than projected Q4 2025 loss while shares tick up modestly today Wall Street Retreats From Recent Broad Rally Amid Rising US Market Pressures New Market Data Shows Market Recap Tech leads sector gains as consumer names lag and markets tick lower JDcom Inc JD COOT Aus Oilseeds posts 161 Q3 2024 revenue growth registers slight share dip on mixed quarterly results DXC Tech DXC Stock Growth Potential Insight DXC Tech posts 15 EPS beat on strong IT demand What is really driving Assembly Bio ASMB stock price movement Q4 2025 EPS Beats Forecasts LBTYK Liberty posts steep Q4 2025 EPS miss even as 124 revenue growth lifts shares modestly Duff Phelps DPG Stock Is It Losing Momentum Quickly On the Radar 20260420 Which Stocks Like General GAM Investors Pile In 20260420 Is Bluejay Diag BJDX stock risky Slight Dip 20260420 Centuri CTRI Stock Trend Analysis Centuri reports 148 EPS miss vs Street estimates Europes Iran ConflictDriven Energy Shock Cost Tally Policy Response and Macroeconomic Implications LegalZoomcom LZ Stock Performance Breakdown Buying Pressure 20260420 Is US USPH stock building bullish momentum 165 20260424 WVVIP Willamette reports Q1 2024 022 per share loss as stock gains 364 percent AbbVie Inc ABBV Submits SKYRIZI Subcutaneous Crohns Regimen to FDA But NearTerm Upside Remains Capped By Competitive Risks CVGW Calavo reports 23 percent Q1 2026 EPS beat shares notch mild gains after quarterly earnings release